Jiangsu Hengrui Pharmaceuticals Co.,Ltd (SHA:600276)
China flag China · Delayed Price · Currency is CNY
57.62
+0.15 (0.26%)
Feb 4, 2026, 2:55 PM CST

SHA:600276 Balance Sheet

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Sep '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Cash & Equivalents
40,36424,81620,74615,11113,63110,805
Trading Asset Securities
111.45273.3499.052,7605,0905,628
Cash & Short-Term Investments
40,47625,08920,84517,87118,72116,433
Cash Growth
76.71%20.36%16.64%-4.54%13.93%21.15%
Accounts Receivable
6,2226,1596,1358,3416,8848,176
Other Receivables
41.566.41438.25562.18658651.15
Receivables
6,2646,2266,5738,9047,5428,827
Inventory
2,7412,4172,3142,4512,4031,778
Prepaid Expenses
-239.54226.07507.2431.57410.18
Other Current Assets
1,9201,3431,3291,2011,090602.25
Total Current Assets
51,40035,31531,28730,93430,18828,050
Property, Plant & Equipment
7,4356,9286,6296,6766,2764,585
Long-Term Investments
1,7831,7321,4511,5081,0011,502
Other Intangible Assets
1,4551,192883.77519.9442.45341.25
Long-Term Deferred Tax Assets
497.84377.17320.56238.9141.3652.97
Long-Term Deferred Charges
5,0344,1122,8292,052569.38197.63
Other Long-Term Assets
723.08479.11383.3442.55648.99-
Total Assets
68,32850,13643,78542,37139,26634,730
Accounts Payable
2,2251,5171,3341,4931,9201,151
Accrued Expenses
5.43941.05578.8597.57165.66130.54
Short-Term Debt
---1,261--
Current Portion of Leases
31.0241.13----
Current Income Taxes Payable
514.97242.9459.284.0321.7725.14
Current Unearned Revenue
3,971159.79198.09187.08219.55358.06
Other Current Liabilities
1,104731.36383.42596.131,0742,107
Total Current Liabilities
7,8523,6342,5543,6393,4023,772
Long-Term Leases
51.4269.0475.1898.86151.59-
Long-Term Unearned Revenue
258.44225.6538.95119.44116.52141.24
Long-Term Deferred Tax Liabilities
133.58117.1183.64100.4524.7729.76
Total Liabilities
8,2954,0452,7513,9583,6943,943
Common Stock
6,6376,3796,3796,3796,3965,332
Additional Paid-In Capital
12,9323,1883,0583,0203,3563,143
Retained Earnings
41,64137,16432,10228,81925,92823,530
Treasury Stock
-1,743-1,229-1,092-398.03-664.94-1,495
Comprehensive Income & Other
36.6616.9719.323.23-12.16-4.79
Total Common Equity
59,50445,52040,46637,82435,00330,504
Minority Interest
528.27570.39567.29589.35568.85282.7
Shareholders' Equity
60,03346,09041,03338,41335,57230,787
Total Liabilities & Equity
68,32850,13643,78542,37139,26634,730
Total Debt
82.44110.1675.181,360151.59-
Net Cash (Debt)
40,39324,97920,77016,51118,57016,433
Net Cash Growth
77.02%20.27%25.79%-11.08%13.00%21.15%
Net Cash Per Share
6.283.943.282.582.912.57
Filing Date Shares Outstanding
6,6716,3626,3616,3676,3826,355
Total Common Shares Outstanding
6,6716,3626,3616,3676,3826,355
Working Capital
43,54831,68128,73427,29526,78624,278
Book Value Per Share
8.927.166.365.945.484.80
Tangible Book Value
58,04944,32839,58237,30434,56130,163
Tangible Book Value Per Share
8.706.976.225.865.424.75
Buildings
-3,9753,8543,5412,7002,141
Machinery
-6,1045,9695,6845,1204,063
Construction In Progress
-1,6881,1011,1931,6591,305
Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.